Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Titel:
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Auteur:
Vrdoljak, E. Marschner, N. Zielinski, C. Gligorov, J. Cortes, J. Puglisi, F. Aapro, M. Fallowfield, L. Fontana, A. Inbar, M. Kahan, Z. Welt, A. Lévy, C. Brain, E. Pivot, X. Putzu, C. González Martín, A. de Ducla, S. Easton, V. von Minckwitz, G.